Home » Stocks » CFX

Colfax Corporation (CFX)

Stock Price: $45.42 USD 0.22 (0.49%)
Updated Jul 26, 2021 4:00 PM EDT - Market closed
Market Cap 6.17B
Revenue (ttm) 3.13B
Net Income (ttm) 57.22M
Shares Out 118.55M
EPS (ttm) 0.41
PE Ratio 110.51
Forward PE 20.75
Dividend n/a
Dividend Yield n/a
Trading Day July 26
Last Price $45.42
Previous Close $45.20
Change ($) 0.22
Change (%) 0.49%
Day's Open 45.23
Day's Range 45.18 - 45.64
Day's Volume 418,363
52-Week Range 26.45 - 50.26

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Colfax (CFX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 days ago - Zacks Investment Research

CFX vs. FLS: Which Stock Is the Better Value Option?

Other stocks mentioned: FLS
1 week ago - Zacks Investment Research

Colfax (CFX) is poised to benefit from strong demand for its products, solid product portfolio, acquired assets and healthy cash flows.

1 week ago - Zacks Investment Research

The Dow Jones rose 30 points, while the S&P 500 rose 0.1%, and Nasdaq was flat. Make the most of this market with today's Top Buys from Q.ai's artificial intelligence.

Other stocks mentioned: EVTC
1 month ago - Forbes

Colfax's (CFX) Q1 earnings surpass estimates and improve year over year on sales and margin improvement. For 2021, it raises bottom-line projections.

2 months ago - Zacks Investment Research

Colfax (CFX) delivered earnings and revenue surprises of 12.82% and 4.49%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Shares of Colfax (NYSE:CFX) were flat in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 15.79% over the past year to $0.44, which beat the estimate o...

2 months ago - Benzinga

ANNAPOLIS JUNCTION, MD, April 29, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its financial results for the first quarter of 2021.

2 months ago - GlobeNewsWire

Colfax (CFX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

2 months ago - Zacks Investment Research

DALLAS--(BUSINESS WIRE)-- #djo--DJO today announced that it has completed the acquisition of MedShape, Inc., a privately held orthopedic medical device company founded in 2005.

3 months ago - Business Wire

Colfax (CFX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

Annapolis Junction, MD, April 14, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financia...

3 months ago - GlobeNewsWire

AUSTIN, Texas--(BUSINESS WIRE)-- #djo--DJO today announced a strategic investment in Insight Medical Systems, a technology company dedicated to wearable surgical navigation in orthopaedics.

3 months ago - Business Wire

Colfax (CFX) to redeem $700 million worth of senior notes that are due to expire in 2024 and 2026. The move will help the company to lower its debt balance.

4 months ago - Zacks Investment Research

Annapolis Junction, MD, March 25, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today that it has given notice ...

4 months ago - GlobeNewsWire

Colfax (CFX) reported earnings 30 days ago. What's next for the stock?

4 months ago - Zacks Investment Research

ANNAPOLIS JUNCTION, MD, March 16, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today the pricing of an underwr...

4 months ago - GlobeNewsWire

Colfax (CFX) offers 14 million common shares to the public in an underwritten offer. The funds raised will be used for funding general corporate purposes and working capital needs.

4 months ago - Zacks Investment Research

ANNAPOLIS JUNCTION, MD, March 15, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today that it has commenced an ...

4 months ago - GlobeNewsWire

Colfax's (CFX) plan of dividing its fabrication technology and medical technology businesses into two separate companies will likely unlock significant values for each of its businesses.

4 months ago - Zacks Investment Research

Colfax (CFX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

4 months ago - Zacks Investment Research

Annapolis Junction, Maryland, March 04, 2021 (GLOBE NEWSWIRE) --  – Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its intention to separate its fabrication te...

4 months ago - GlobeNewsWire

Annapolis Junction, Maryland, March 04, 2021 (GLOBE NEWSWIRE) --  – Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its intention to separate its fabrication te...

4 months ago - GlobeNewsWire

Annapolis Junction, MD, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it has appointed Philip Okala, Chief Operating Of...

5 months ago - GlobeNewsWire

Colfax's (CFX) Q4 earnings decrease year over year, reflecting the impacts of weak sales generation and a decline in margins. For 2021, it anticipates y/y revenue and earnings growth.

5 months ago - Zacks Investment Research

Colfax (CFX) delivered earnings and revenue surprises of 4.08% and -0.25%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

•         Reported $0.29 EPS from continuing operations and achieved $0.51 of adjusted EPS•         Recently acquired two high-growth, high-gross margin medical technology businesses  •         Announce...

5 months ago - GlobeNewsWire

Annapolis Junction, MD, Jan. 29, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial...

5 months ago - GlobeNewsWire

A recap for my 20/20 Vision is offered for my readers. I will share my concerns about the current market conditions.

Other stocks mentioned: AMPH, AQUA, BBDC, BHVN, CRHM, GBT, HASI ...
6 months ago - Seeking Alpha

Colfax (CFX) arm DJO closes buyout of Trilliant Surgical, which will boost its product offerings and growth prospects in the foot and ankle surgery market.

6 months ago - Zacks Investment Research

After reaching record highs last week, the major indices sold off Monday and have since failed to stage a significant rally. For now, stocks look overstretched, and inflation could be right around corner.

Other stocks mentioned: BLMN, FUN, USFD
6 months ago - Forbes

The industrial sector is gearing up for growth in 2021. ParkerHannifin (PH), Fortune Brands (FBHS), Reliance Steel (RS), Rexnord (RXN) and Colfax (CFX) are performing well and are set to grow.

Other stocks mentioned: FBHS, PH, RS, RXN
6 months ago - Zacks Investment Research

Let's see if Colfax (CFX) stock is a good choice for value-oriented investors right now from multiple angles.

6 months ago - Zacks Investment Research

Colfax's (CFX) acquisition of LiteCure will create strong growth opportunities for DJO in the physical therapy and rehabilitation market.

7 months ago - Zacks Investment Research

Colfax's (CFX) product launches, exposure in multiple markets and gains from buyouts to prove beneficial. However, the pandemic-led challenges and lower selling days remain concerning for Q4.

7 months ago - Zacks Investment Research

Colfax's (CFX) Q3 earnings reflect the impacts of poor product demand due to the pandemic, forex woes and a fall in margin. For Q4, it predicts a sequential rise in sales and earnings.

8 months ago - Zacks Investment Research

Colfax Corporation (CFX) CEO Matt Trerotola on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Colfax (CFX) delivered earnings and revenue surprises of 2.50% and 6.13%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

ANNAPOLIS JUNCTION, MD, Oct. 29, 2020 (GLOBE NEWSWIRE) --  Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced its financial results for the third quarter of 2020.

8 months ago - GlobeNewsWire

Colfax (CFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

Annapolis Junction, MD, Oct. 14, 2020 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company, today announced that it will issue a press release providing financial...

9 months ago - GlobeNewsWire

Colfax (CFX) to benefit from growth opportunities in the Fabrication Technology and Medical Technology segments. Also, business in multiple end markets and cost-reduction actions are other tailwinds.

9 months ago - Zacks Investment Research

Colfax's (CFX) focus on innovation and product launches along with cost-saving measures might aid performances in the quarters ahead. Adversities caused by the pandemic and high debts are concerning.

10 months ago - Zacks Investment Research

It appears that investors are starting to take their chips off the table after an incredible run off the coronavirus-led market lows in March. For investors who anticipate that this wave of sell-offs wi...

Other stocks mentioned: GT, NAV, PLUG, VTR
10 months ago - Forbes

Colfax (CFX) reported earnings 30 days ago. What's next for the stock?

10 months ago - Zacks Investment Research

Colfax's Rate Of Recovery Will Demonstrate The Strength Of Newly Transformed Portfolio

10 months ago - Seeking Alpha

Colfax's (CFX) CEO Matt Trerotola on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Colfax's (CFX) Q2 results reflect the adverse impacts of the pandemic on product demand and forex woes. It predicts generating sequentially higher profits and positive cash flow in Q3.

11 months ago - Zacks Investment Research

Colfax (CFX) delivered earnings and revenue surprises of 50.00% and 2.91%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

11 months ago - Zacks Investment Research

About CFX

Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as el... [Read more...]

Industry
Specialty Industrial Machinery
IPO Date
May 8, 2008
CEO
Matthew Trerotola
Employees
15,400
Stock Exchange
NYSE
Ticker Symbol
CFX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 18 analysts, the average rating for CFX stock is "Buy." The 12-month stock price forecast is 52.36, which is an increase of 15.28% from the latest price.

Price Target
$52.36
(15.28% upside)
Analyst Consensus: Buy